This study further demonstrates the applicability of lentiviral based shRNA for conducting phenotypic screens to identify targets involved in a variety of biological processes, and establishes MAP3K11, DGKD, ICK, CIT, GALK2, and PSKH1 as regulators of prostate cancer cell growth. Here, MAP3K11 is linked to prostate carcinoma.